Search research articles
Contact Us
Filters
Showing results (311-320 of 509) with videos related to
Page
of 51
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 12, 2023
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial
Renaud Sabatier, Frédérique Rousseau, Florence Joly, et al.
British Journal of Cancer
|
May 3, 2017
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies
Rastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, et al.
BMC Health Services Research
|
March 30, 2012
Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions
Lionel Perrier, Alessandra Buja, Giuseppe Mastrangelo, et al.
Bulletin Du Cancer
|
April 12, 2023
[Treatments for rare ovarian tumors: What's new?]
Coriolan Lebreton, Stanislas Quesada, Marta Bini, et al.
Gynecologic Oncology
|
June 26, 2026
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network
Thomas Montassier, Enora Laas, Judicael Hotton, et al.
Journal of Personalized Medicine
|
April 23, 2022
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3
Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
George D Demetri, Paolo G Casali, Jean-Yves Blay, et al.
Gynecologic Oncology
|
July 30, 2020
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)
Félix Blanc-Durand, Claudia Lefeuvre-Plesse, Isabelle Ray-Coquard, et al.
The New England Journal of Medicine
|
September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma
Patricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 2, 2023
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors
Ulrika Joneborg, Alice Bergamini, Emelie Wallin, et al.
Page
of 51
Search research articles
Search
Showing results (311-320 of 509) with videos related to
Sort By:
Page
of 51
European Journal of Cancer (Oxford, England : 1990)
|
January 12, 2023
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial
Renaud Sabatier, Frédérique Rousseau, Florence Joly, et al.
British Journal of Cancer
|
May 3, 2017
Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies
Rastislav Bahleda, Juneko E Grilley-Olson, Ramaswamy Govindan, et al.
BMC Health Services Research
|
March 30, 2012
Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions
Lionel Perrier, Alessandra Buja, Giuseppe Mastrangelo, et al.
Bulletin Du Cancer
|
April 12, 2023
[Treatments for rare ovarian tumors: What's new?]
Coriolan Lebreton, Stanislas Quesada, Marta Bini, et al.
Gynecologic Oncology
|
June 26, 2026
Prognostic impact of time to first recurrence in low-grade serous ovarian carcinoma: A multicentric retrospective study from the French TMRG network
Thomas Montassier, Enora Laas, Judicael Hotton, et al.
Journal of Personalized Medicine
|
April 23, 2022
A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3
Christelle de la Fouchardière, Pia Gamradt, Sylvie Chabaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
George D Demetri, Paolo G Casali, Jean-Yves Blay, et al.
Gynecologic Oncology
|
July 30, 2020
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)
Félix Blanc-Durand, Claudia Lefeuvre-Plesse, Isabelle Ray-Coquard, et al.
The New England Journal of Medicine
|
September 4, 2024
Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma
Patricia Pautier, Antoine Italiano, Sophie Piperno-Neumann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 2, 2023
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors
Ulrika Joneborg, Alice Bergamini, Emelie Wallin, et al.
Page
of 51